Palisade Bio, Inc. (PALI) Balance Sheet
PALI balance sheet, 2025
December 31, 2025 · U.S. dollars$134.3M assets = $5.0M liabilities + $129.4M equity
Both columns are drawn to the same scale: what PALI owns equals what it owes plus shareholders’ equity. Hover a block for its value.
PALI financial health
Descriptive bands, not a rating. Fiscal 2025.
PALI balance sheet trends, 2016–2025
| Metric | Trend | Then | Latest | Change |
|---|---|---|---|---|
| Total assets | $22.6M2016 | $134.3M2025 | +21.9%/yr | |
| Total liabilities | $11.3M2016 | $5.0M2025 | −8.7%/yr | |
| Shareholders’ equity | $11.3M2016 | $129.4M2025 | +31.1%/yr | |
| Cash & short-term investments | $20.2M2016 | $133.4M2025 | +23.3%/yr | |
| Total debt | $3.7M2016 | $71,0002025 | −35.6%/yr | |
| Net cash (debt) | $16.5M2016 | $133.3M2025 | +$116.8M | |
| Working capital | $13.6M2016 | $129.6M2025 | +$116.0M | |
| Debt / equity | 0.332016 | 0.002025 | −0.33 |
Change is the average annual growth (CAGR) or the difference between the first and latest year.
PALI assets
PALI liabilities and equity
PALI debt vs cash
Debt includes short- and long-term borrowings and, where reported, lease obligations.
PALI balance sheet
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Cash & short-term investments | $133.4M | $9.8M | $12.4M | $12.4M | $10.5M | $729,000 | $5.1M | $5.8M | $11.7M | $20.2M |
| Cash & equivalents | $133.4M | $9.8M | $12.4M | $12.4M | $10.5M | $713,000 | $5.1M | $5.8M | $6.7M | $15.2M |
| Short-term investments | — | — | — | — | — | $16,000 | — | — | $5.0M | $5.0M |
| Receivables | $264,000 | $24,000 | $148,000 | $1.4M | $150,000 | $59,000 | $21,064 | $357,995 | $371,586 | $63,572 |
| Inventory | $0 | $12,000 | $0 | −$1.4M | −$150,000 | −$2.2M | $0 | $0 | $0 | $0 |
| Other current assets | $572,000 | $637,000 | $748,000 | $2.4M | $1.0M | $2.3M | $510,900 | $363,288 | $402,273 | $646,195 |
| Total current assets | $134.2M | $10.5M | $13.3M | $14.7M | $11.5M | $896,000 | $5.6M | $6.5M | $12.4M | $20.9M |
| Property, plant & equipment (net) | $0 | $87,000 | $208,000 | $310,000 | $112,000 | $280,000 | $242,736 | $90,311 | $172,886 | $269,557 |
| Goodwill & intangible assets | $0 | $0 | $0 | $0 | $0 | $147,130 | $668,936 | $763,543 | $883,462 | $990,153 |
| Long-term investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other non-current assets | $123,000 | $299,000 | $516,000 | $720,000 | $894,000 | $1.7M | $25,336 | $322,203 | $379,309 | $439,902 |
| Total assets | $134.3M | $10.9M | $14.1M | $15.8M | $12.5M | $3.0M | $6.6M | $7.7M | $13.9M | $22.6M |
| Liabilities | ||||||||||
| Accounts payable | $767,000 | $1.2M | $698,000 | $1.8M | $1.5M | $2.5M | $824,406 | $832,564 | $875,065 | $2.3M |
| Short-term debt | $71,000 | $169,000 | $279,000 | $193,000 | $199,000 | $1.2M | $140,000 | — | — | $3.7M |
| Deferred revenue | — | — | — | — | — | — | — | −$4.5M | — | — |
| Total current liabilities | $4.6M | $3.2M | $2.6M | $3.0M | $2.5M | $8.1M | $1.2M | $1.1M | $1.5M | $7.3M |
| Long-term debt | $0 | $0 | $0 | $0 | $0 | $94,000 | $0 | $0 | $0 | $0 |
| Lease obligations | $0 | $90,000 | $211,000 | $316,000 | $112,000 | $280,000 | — | — | — | — |
| Other long-term liabilities | $328,000 | $152,000 | $153,000 | $272,000 | $2.7M | $1.9M | $233,138 | $583,734 | $3.9M | $3.9M |
| Total liabilities | $5.0M | $3.4M | $2.7M | $3.3M | $5.1M | $10.1M | $1.5M | $1.6M | $5.4M | $11.3M |
| Shareholders' equity | ||||||||||
| Common stock & paid-in capital | $1.6M | $27,000 | $93,000 | $30,000 | $3,000 | $28,000 | $38,665 | $182,051 | $151,600 | $110,329 |
| Retained earnings (deficit) | −$152.7M | −$135.9M | −$121.5M | −$109.2M | −$94.6M | −$68.0M | −$222.0M | −$213.6M | −$208.7M | −$193.0M |
| Accumulated other comprehensive income | — | — | $0 | — | — | −$734 | −$6,186 | −$413 | $2,631 | $3,905 |
| Total shareholders' equity | $129.4M | $7.5M | $11.3M | $12.5M | $7.4M | −$7.1M | $5.1M | $6.0M | $8.5M | $11.3M |
| Key figures | ||||||||||
| Total debt | $71,000 | $169,000 | $369,000 | $404,000 | $199,000 | $1.4M | $288,543 | $5.0M | — | $3.7M |
| Net cash (debt) | $133.3M | $9.7M | $12.1M | $12.0M | $10.3M | −$692,000 | $4.8M | $749,110 | — | $16.5M |
| Working capital | $129.6M | $7.3M | $10.7M | $11.7M | $9.0M | −$7.2M | $4.4M | $5.5M | $10.9M | $13.6M |
| Tangible book value | $129.4M | $7.5M | $11.3M | $12.5M | $7.4M | −$7.2M | $4.5M | $5.3M | $7.6M | $10.3M |
| Book value per share | $2.32 | — | — | — | — | — | — | — | — | — |
| Shares outstanding | 55.7M | — | — | — | — | — | — | — | — | — |
| Current ratio | 28.95 | 3.24 | 5.15 | 4.89 | 4.61 | 0.11 | 4.61 | 6.19 | 8.22 | 2.85 |
| Quick ratio | 28.83 | 3.04 | 4.86 | 4.59 | 4.26 | 0.10 | 4.19 | 5.85 | 7.95 | 2.76 |
| Debt / equity | 0.00 | 0.02 | 0.03 | 0.03 | 0.03 | — | 0.06 | 0.83 | — | 0.33 |
| Equity / assets | 96.3% | 68.9% | 80.5% | 79.2% | 58.9% | −235.1% | 77.9% | 78.7% | 61.3% | 50.1% |
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 | Jun '24 | Mar '24 | Dec '23 | Sep '23 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||
| Cash & short-term investments | $125.2M | $132.6M | $133.4M | $5.2M | $5.4M | $7.2M | $9.8M | $8.0M | $11.4M | $11.3M | $12.4M | $15.3M |
| Cash & equivalents | $125.2M | $132.6M | $133.4M | $5.2M | $5.4M | $7.2M | $9.8M | $8.0M | $11.4M | $11.3M | $12.4M | $15.3M |
| Receivables | $500,000 | $9,000 | $264,000 | $18,000 | $6,000 | $78,000 | $24,000 | $96,000 | $128,000 | $153,000 | $148,000 | $135,000 |
| Inventory | $0 | $0 | $0 | $0 | $0 | $0 | $0 | −$96,000 | $0 | $0 | $0 | −$135,000 |
| Other current assets | $1.6M | $606,000 | $572,000 | $1.6M | $1.0M | $579,000 | $649,000 | $830,000 | $831,000 | $584,000 | $748,000 | $954,000 |
| Total current assets | $127.3M | $133.2M | $134.2M | $6.8M | $6.4M | $7.9M | $10.5M | $8.9M | $12.3M | $12.0M | $13.3M | $16.3M |
| Property, plant & equipment (net) | $0 | $0 | $0 | $0 | $23,000 | $55,000 | $87,000 | $116,000 | $146,000 | $175,000 | $208,000 | $234,000 |
| Goodwill & intangible assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-term investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other non-current assets | $55,000 | $72,000 | $123,000 | $145,000 | $197,000 | $248,000 | $299,000 | $350,000 | $413,000 | $464,000 | $516,000 | $567,000 |
| Total assets | $127.3M | $133.3M | $134.3M | $7.0M | $6.7M | $8.2M | $10.9M | $9.3M | $12.9M | $12.7M | $14.1M | $17.1M |
| Liabilities | ||||||||||||
| Accounts payable | $1.8M | $2.7M | $930,000 | $1.4M | $1.8M | $942,000 | $1.2M | $366,000 | $514,000 | $548,000 | $698,000 | $1.3M |
| Short-term debt | — | — | $71,000 | $211,000 | $338,000 | $58,000 | $169,000 | $357,000 | $479,000 | $125,000 | $279,000 | $376,000 |
| Deferred revenue | — | — | — | — | — | — | — | — | — | −$125,000 | — | −$616,000 |
| Total current liabilities | $5.2M | $5.6M | $4.6M | $3.5M | $4.0M | $2.8M | $3.2M | $2.7M | $2.8M | $2.5M | $2.6M | $2.6M |
| Long-term debt | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Lease obligations | — | — | $0 | $0 | $24,000 | $58,000 | $90,000 | $122,000 | $154,000 | $183,000 | $211,000 | $239,000 |
| Other long-term liabilities | $321,000 | $333,000 | $328,000 | $283,000 | $77,000 | $82,000 | $152,000 | $47,000 | $86,000 | $121,000 | $153,000 | $336,000 |
| Total liabilities | $5.6M | $6.0M | $5.0M | $3.8M | $4.0M | $2.9M | $3.4M | $2.7M | $2.9M | $2.6M | $2.7M | $3.0M |
| Shareholders' equity | ||||||||||||
| Common stock & paid-in capital | $1.7M | $1.7M | $1.6M | $91,000 | $48,000 | $43,000 | $27,000 | $11,000 | $9,000 | $8,000 | $93,000 | $92,000 |
| Retained earnings (deficit) | −$172.9M | −$162.3M | −$152.7M | −$143.8M | −$141.0M | −$138.2M | −$135.9M | −$132.6M | −$129.1M | −$125.0M | −$121.5M | −$118.5M |
| Accumulated other comprehensive income | — | — | — | — | — | — | — | — | −$2,000 | $0 | $0 | −$2,000 |
| Total shareholders' equity | $121.7M | $127.4M | $129.4M | $3.2M | $2.6M | $5.3M | $7.5M | $6.6M | $9.9M | $10.1M | $11.3M | $14.1M |
| Key figures | ||||||||||||
| Total debt | — | — | $71,000 | $211,000 | $338,000 | $58,000 | $169,000 | $357,000 | $503,000 | $183,000 | $369,000 | $498,000 |
| Net cash (debt) | — | — | $133.3M | $5.0M | $5.1M | $7.2M | $9.7M | $7.7M | $10.8M | $11.1M | $12.1M | $14.8M |
| Working capital | $122.0M | $127.6M | $129.6M | $3.4M | $2.5M | $5.1M | $7.3M | $6.2M | $9.5M | $9.5M | $10.7M | $13.6M |
| Tangible book value | $121.7M | $127.4M | $129.4M | $3.2M | $2.6M | $5.3M | $7.5M | $6.6M | $9.9M | $10.1M | $11.3M | $14.1M |
| Book value per share | $0.58 | $0.61 | $2.32 | — | — | — | — | — | — | — | — | — |
| Shares outstanding | 211.4M | 209.7M | 55.7M | — | — | — | — | — | — | — | — | — |
| Current ratio | 24.26 | 23.71 | 28.95 | 1.96 | 1.62 | 2.84 | 3.24 | 3.31 | 4.34 | 4.87 | 5.15 | 6.14 |
| Quick ratio | 23.96 | 23.60 | 28.83 | 1.51 | 1.37 | 2.63 | 3.04 | 3.03 | 4.05 | 4.63 | 4.86 | 5.83 |
| Debt / equity | — | — | 0.00 | 0.07 | 0.13 | 0.01 | 0.02 | 0.05 | 0.05 | 0.02 | 0.03 | 0.04 |
| Equity / assets | 95.6% | 95.5% | 96.3% | 46.1% | 39.3% | 65.1% | 68.9% | 70.8% | 77.3% | 79.5% | 80.5% | 82.5% |
Quarterly columns are labeled by the month the quarter ended. Figures in U.S. dollars as reported (latest annual report filed March 20, 2026); data from EODHD.
PALI financial position
At the end of fiscal 2025 (December 31, 2025), Palisade Bio had total assets of $134.3 million (up 1,134.8% from a year earlier), total liabilities of $5.0 million and shareholders' equity of $129.4 million. It held $133.4 million in cash and short-term investments against $0.1 million of debt, a net cash position of $133.3 million. Its current ratio was 28.95. In the latest quarter (ended June 30, 2026) total assets were $127.3 million and equity $121.7 million.
Related: PALI income statement, PALI cash flow statement, PALI key metrics. See the PALI stock overview for the latest quote and news.
PALI balance sheet FAQ
What are Palisade Bio's total assets?
Palisade Bio reported total assets of $134.3 million at the end of fiscal 2025 (December 31, 2025), compared with $10.9 million a year earlier.
How much debt does Palisade Bio have?
Palisade Bio had $0.1 million of total debt at the end of fiscal 2025, including short-term borrowings. Its debt-to-equity ratio was 0.00.
How much cash does Palisade Bio have?
Palisade Bio held $133.4 million in cash and short-term investments at the end of fiscal 2025; with $0.1 million of debt that is net cash of $133.3 million.
What is Palisade Bio's book value?
Palisade Bio's shareholders' equity (book value) was $129.4 million at the end of fiscal 2025, or $2.32 per share.
What is Palisade Bio's current ratio?
Palisade Bio had current assets of $134.2 million and current liabilities of $4.6 million, a current ratio of 28.95 (it can cover its short-term obligations).